| Literature DB >> 23817844 |
K Andrae1, V Durmaz, K Fackeldey, O Scharkoi, M Weber.
Abstract
Small molecules can have a significant effect on human metabolic processes. Computational drug design aims at constructing specialized small molecules that selectively and efficiently address specific proteins. The basic ideas of computational molecular design are presented and it will be shown how a virtual protein can be computer designed. This virtual protein can be used to predict the binding affinity of given small molecules without having to synthesize them in a laboratory. Modern computational drug design goes far beyond the lock and key principle. Possible future developments are discussed and a current successful example of computational drug design in the field of painkiller medication is demonstrated.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23817844 DOI: 10.1007/s00101-013-2202-x
Source DB: PubMed Journal: Anaesthesist ISSN: 0003-2417 Impact factor: 1.041